Citadel Advisors »

Kyverna Therapeutics shares owned by Citadel Advisors

Quarter-by-quarter ownership of Kyverna Therapeutics (KYTX) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Kyverna Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kyverna Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kyverna Therapeutics by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2024-06-30 $1.9M 248k 7.50
2024-03-31 $13M 531k 24.84

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
NVIDIA Corporation Call Option (NVDA)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Apple Call Option (AAPL)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Tesla Motors Call Option (TSLA)
Microsoft Corporation Call Option (MSFT)
Meta Platforms Cl A Call Option (META)
Amazon Call Option (AMZN)
Broadcom Call Option (AVGO)
Advanced Micro Devices Call Option (AMD)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl C Call Option (GOOG)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)

View all positions for Citadel Advisors

Top funds holding Kyverna Therapeutics

Vida Ventures Advisors
Bain Capital Life Sciences Investors
Northpond Ventures
Jpmorgan Chase & Co
Deerfield Management Company
Novo A/S
BlackRock
Vanguard Group
Millennium Management
Insight Holdings
Franklin Resources
T. Rowe Price Associates
Casdin Capital
Dr. Jeffrey R. Jay, M.D.
EcoR1 Capital

View all funds holding Kyverna Therapeutics